MIR503HG and ovarian cancer: In conclusion, MIR503HG expression was downregulated in ovarian tumor tissues and cells, and MIR503HG overexpression impaired the proliferative, invasive and EMT properties, and facilitated cell apoptosis in ovarian cancer cells.